Schizophrenia, Bipolar and Major Depressive Disorders: Overview of Clinical Features, Neurotransmitter Alterations, Pharmacological Interventions, and Impact of Oxidative Stress in the Disease Process-Reference-Cited by-同舟云学术

Schizophrenia, Bipolar and Major Depressive Disorders: Overview of Clinical Features, Neurotransmitter Alterations, Pharmacological Interventions, and Impact of Oxidative Stress in the Disease Process

Published:2022-09-20 Issue:19 Volume:13 Page:2784-2802
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Mandal Pravat K¹²^ORCID,Gaur Shradha¹,Roy Rimil Guha¹,Samkaria Avantika¹,Ingole Ratnarakshit³,Goel Anshika¹

Affiliation:

1. Neuroimaging and Neurospectroscopy (NINS) Laboratory, National Brain Research Centre, Manesar, Haryana 122050, India

2. The Florey Institute of Neuroscience and Mental Health, Melbourne School of Medicine Campus, Melbourne 3052, Australia

3. Tulasi Healthcare, Gurugram, Haryana 122102, India

Funder

Ministry of Electronics and Information technology

Department of Biotechnology, Ministry of Science and Technology, India

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.2c00420

Reference207 articles.

1. World Mental Health Day: an opportunity to kick-start a massive scale-up in investment in mental health. World Health Organization: Geneva, 2020.

2. Challenges and Opportunities in Global Mental Health: a Research-to-Practice Perspective

3. Treatment resistance in psychiatry: state of the art and new directions

4. Oxidative Stress in Schizophrenia

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ElectroRetinoGraphy toward an exploration of the therapeutic potential of antidepressants in patients with major depressive disorder: A scoping review of the literature;Neuroscience & Biobehavioral Reviews;2024-09

2. Quantification of glutathione and its associated spontaneous neuronal activity in major depressive disorder and obsessive-compulsive disorder;Biological Psychiatry;2024-08

3. Establishment of a Mitochondrial Metabolism-Related Diagnostic Model in Schizophrenia Based on LASSO Algorithm;Psychiatry Investigation;2024-06-25

4. Assessing the associations of 1,400 blood metabolites with major depressive disorder: a Mendelian randomization study;Frontiers in Psychiatry;2024-06-06

5. Association between cognitive function, antioxidants, and clinical variables in Chinese patients with schizophrenia;2024-06-04